9.96
Viking Acquisition Corp I stock is traded at $9.96, with a volume of 200.
It is up +0.40% in the last 24 hours and up +0.10% over the past month.
Viking Acquisition Corp I is a blank check company.
See More
Previous Close:
$9.92
Open:
$9.96
24h Volume:
200
Relative Volume:
0.00
Market Cap:
$312.01M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.50%
1M Performance:
+0.10%
6M Performance:
+0.00%
1Y Performance:
+0.00%
Viking Acquisition Corp I Stock (VACI) Company Profile
Name
Viking Acquisition Corp I
Sector
Industry
Phone
(631) 353-2402
Address
900 THIRD AVENUE, 10TH FLOOR, NEW YORK
Compare VACI vs LION, XXI, UMAC, DMII, BCSS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
VACI
Viking Acquisition Corp I
|
9.96 | 312.01M | 0 | 0 | 0 | 0.00 |
|
LION
Lionsgate Studios Corp
|
9.77 | 2.84B | 3.13B | -174.20M | -111.20M | -0.6937 |
|
XXI
Twenty One Capital Inc
|
7.04 | 2.44B | 0 | 0 | 0 | 0.00 |
|
UMAC
Unusual Machines Inc
|
19.84 | 756.10M | 0 | -5.28M | -3.11M | -0.6947 |
|
DMII
Drugs Made In America Acquisition Ii Corp
|
9.95 | 652.47M | 0 | 0 | 0 | -0.0028 |
|
BCSS
Bain Capital Gss Investment Corp
|
10.15 | 592.76M | 0 | 0 | 0 | 0.00 |
Viking Acquisition Corp I Stock (VACI) Latest News
Viking Acquisition Corp. I Stock Forecast Summary - Meyka
VACI Should I Buy - Intellectia AI
RNGT Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
M&G PLC Purchases Shares of 197,365 Viking Holdings Ltd. $VIK - MarketBeat
Viking M&A Expands Into Philadelphia, Targeting Surging Mid-Market Demand - MyChesCo
‘High-grade’ tungsten validates Viking’s Linka acquisition - Mining.com.au
Viking M&A Expands into Philadelphia - citybiz
Acquisition Buzz and Clinical Progress Fuel Viking Therapeutics Momentum - AD HOC NEWS
Viking Therapeutics Gains Momentum Amid Acquisition Chatter - AD HOC NEWS
Acquisition Speculation Fuels Momentum for Viking Therapeutics Stock - AD HOC NEWS
Viking Therapeutics: M&A Buzz and Clinical Progress Fuel Biotech Speculation - AD HOC NEWS
Viking Therapeutics Stock (VKTX) Opinions on VK2735 Obesity Drug Results - Quiver Quantitative
Viking Therapeutics Stock Surges on Clinical Success and Acquisition Buzz - AD HOC NEWS
Readers rank Viking best for river cruises, ocean cruises, dining and more - Stock Titan
Viking’s Linka acquisition shows tungsten results - Mining.com.au
How Viking Holdings Ltd Ordinary Shares stock performs during market turbulenceJuly 2025 Intraday Action & Expert Approved Momentum Ideas - Улправда
Viking Mines enters into US tungsten ground - Mining.com.au
Long term debt to total equity ratio of Viking Acquisition Corp. I Warrant -on Viking Acqn – NYSE:VACI/W - TradingView — Track All Markets
American Tungsten Announces Strategic Investment in Viking Mines - InvestorNews
Viking Mines (ASX:VKA) Acquires Nevada Tungsten Portfolio in Strategic US Expansion - Kalkine Media
Viking Acquisition Corp I SEC 10-Q Report - TradingView — Track All Markets
VACI-UN SEC Filings - Stock Titan
Viking Acquisition Corp. I Reports Earnings Results for the Two Months Ended September 30, 2025 - marketscreener.com
Viking Therapeutics Shares Maintain Upward Momentum on Clinical and Strategic Catalysts - AD HOC NEWS
Viking Therapeutics Stock Surges on Regulatory and Acquisition Catalysts - AD HOC NEWS
Viking Recognized in Cruise Critic’s 2025 Best in Cruise Awards - Yahoo Finance
Viking Therapeutics Stock Surges on Clinical Momentum and Acquisition Buzz - Ad-hoc-news.de
Viking Therapeutics Emerges as a Prime Acquisition Candidate Amid Obesity Drug Advancements - AD HOC NEWS
Asset turnover of Viking Acquisition Corp. I – NYSE:VACI - TradingView
Viking Therapeutics Emerges as a Prime Acquisition Target Following Trial Success - AD HOC NEWS
Viking Acquisition Corp. I Warrant -on Viking Acqn Revenue Breakdown – NYSE:VACI/W - TradingView
Jefferies Projects Strong 2026 Performance for Viking Holdings’ Ocean, River Segments; Capital Strategy Favors Growth ROI - Yahoo Finance
350,000 Units of Viking Acquisition Corp. I are subject to a Lock-Up Agreement Ending on 30-NOV-2025. - marketscreener.com
Viking Therapeutics Faces Renewed Pressure as Pfizer Enters Obesity Drug Race - AD HOC NEWS
Total liabilities & shareholders' equities of Viking Acquisition Corp. I Warrant -on Viking Acqn – BOATS:VACI/W - TradingView
Inventory turnover of Viking Acquisition Corp. I Warrant -on Viking Acqn – BOATS:VACI/W - TradingView
NYSE Content Advisory: Pre-Market update + BLS Reveals First Look at Labor Market Since September - Sahm
Basic earnings per share (basic EPS) of Viking Acquisition Corp. I Warrant -on Viking Acqn – NYSE:VACI/W - TradingView
Diluted net income available to common stockholders of Viking Acquisition Corp. I – BOATS:VACI - TradingView
Check out Viking Acquisition Corp I's stock price (VACI) in real time - CNBC
Diluted net income available to common stockholders of Viking Acquisition Corp. I – NYSE:VACI - TradingView
Viking Acquisition Corp. I (VACI) - Zacks Investment Research
Viking Acquisition Corp. I Income Statement – NYSE:VACI - TradingView
VACI Price History for Viking Acquisition Corp. I Cl A Stock - Barchart.com
Viking Acquisition Corp. I (VACI-UN) Company Profile & Facts - Yahoo! Finance Canada
VACI: Static price chart | Viking Acquisition Corp. I | KYG9582G1047 - MarketScreener
Enterprise value to EBITDA ratio of Viking Acquisition Corp. I Warrant -on Viking Acqn – NYSE:VACI/W - TradingView
Operating margin % of Viking Acquisition Corp. I Warrant -on Viking Acqn – BOATS:VACI/W - TradingView
Basic earnings per share (basic EPS) of Viking Acquisition Corp. I – NYSE:VACI - TradingView
Total revenue of Viking Acquisition Corp. I – NYSE:VACI - TradingView
EBITDA of Viking Acquisition Corp. I – NYSE:VACI - TradingView
Viking Acquisition Corp I Stock (VACI) Financials Data
There is no financial data for Viking Acquisition Corp I (VACI). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):